Lgr5+ somatic stem cells
US11492592B2 · kind B2 · utility
0Cited by
20References
12Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 7, 2019 |
| Grant date | Nov 8, 2022 |
| Priority date | — |
| Expiry date | Aug 8, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N5/0663
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for treating a condition, comprising administering to a subject in need thereof a composition that contains somatic stem cells that are 2 to less than 6 micrometers in size and Lgr5+, wherein the condition is selected from the group consisting of neurodegenerative disorder, muscle-degenerative disease, cancer, metabolic disorder, autoimmune disorder, inflammatory disorder, heart disorder, circulatory disorder, a condition associated with aging, and damaged tissue.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.